Johnson & Johnson (JNJ) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Johnson & Johnson’s Covid-19 single-shot vaccine was shown to be 66% effective in preventing moderate and severe disease in a global Phase 3 trial, but 85% effective against severe disease, the ...

Johnson & Johnson (NYSE:JNJ) is one of the 10 Best Dip Stocks to Buy According to Billionaires. On June 26, J.P.

Johnson & Johnson (NYSE:JNJ) ranks among the best set-it-and-forget-it stocks to buy. Asad Haider, a Goldman Sachs analyst, ...

The company at the center of quality problems that led Johnson & Johnson to discard 15 million doses of its coronavirus vaccine has a string of citations from U.S. health officials fo… ...

Johnson & Johnson is named in a proposed class action lawsuit alleging the company used fraudulent transactions to file for bankruptcy various times.

Johnson & Johnson's vaccine, made by the company's Janssen subsidiary, was shown to be 86 percent effective in preventing severe forms of Covid-19, and it received emergency use authorization from ...

Johnson & Johnson has seen faster growth in its pharmaceutical business, home to its single-shot coronavirus vaccine, compared with other parts of the company. In the year ended Sept. 30, the unit ...

The 135-year-old company announced plans to divide itself into a consumer products business and a medical company. By Rebecca Robbins and Michael J. de la Merced For generations, Johnson & Johnson ...

A Missouri appeals court on Tuesday ordered Johnson & Johnson and a subsidiary to pay $2.1 billion in damages to women who blamed their ovarian cancers on the company’s talcum products ...

A bankruptcy judge dismissed Johnson & Johnson’s third attempt to resolve its mass talc liabilities through chapter 11, rejecting the company’s latest bid to end one of the largest-ever mass ...